Literature DB >> 27875812

Hemodialysis Decreases the Etiologically-Related Early Vascular Aging Observed in End-Stage Renal Disease: A 5-Year Follow-Up Study.

Daniel Bia1, Cintia Galli, Yanina Zócalo, Rodolfo Valtuille, Sandra Wray, Ricardo Armentano, Edmundo Cabrera-Fischer.   

Abstract

AIMS: To analyze the early vascular aging (EVA) in end-stage renal disease (ESRD) patients, attempting to determine a potential association between EVA and the etiology of ESRD, and to investigate the association of hemodialysis and EVA in ESRD patients during a 5-year follow-up period.
METHODS: Carotid-femoral pulse wave velocity (cfPWV) was obtained in 151 chronically hemodialyzed patients (CHP) and 283 control subjects, and in 25 CHP, who were followed-up after a 5-year lapse.
RESULTS: cfPWV increased in ESRD patients compared to control subjects. The cfPWV-age relationship was found to have a steeper increase in ESRD patients. The highest cfPWV and EVA values were observed in patients with diabetic nephropathy. Regression analysis demonstrated a significant reduction of the EVA in HD patients on a 5-year follow-up.
CONCLUSION: Patients in ESRD showed higher levels of EVA. cfPWV and EVA differed in ESRD patients depending on their renal failure etiology. CHP showed an EVA reduction after a 5-year follow-up period.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2016        PMID: 27875812     DOI: 10.1159/000448986

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  2 in total

1.  Aortic-Radial Pulse Wave Velocity Ratio in End-stage Renal Disease Patients: Association with Age, Body Tissue Hydration Status, Renal Failure Etiology and Five Years of Hemodialysis.

Authors:  Daniel Bia; Rodolfo Valtuille; Cintia Galli; Sandra Wray; Ricardo Armentano; Yanina Zócalo; Edmundo Cabrera-Fischer
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-01-19

Review 2.  Quantitative Vascular Evaluation: From Laboratory Experiments to Point-of-Care Patient (Clinical Approach).

Authors:  Ricardo L Armentano; Leandro J Cymberknop
Journal:  Curr Hypertens Rev       Date:  2018
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.